CN116024219A - Termite black-bone antibacterial peptide Oftermicin2 gene and application thereof - Google Patents
Termite black-bone antibacterial peptide Oftermicin2 gene and application thereof Download PDFInfo
- Publication number
- CN116024219A CN116024219A CN202111256412.8A CN202111256412A CN116024219A CN 116024219 A CN116024219 A CN 116024219A CN 202111256412 A CN202111256412 A CN 202111256412A CN 116024219 A CN116024219 A CN 116024219A
- Authority
- CN
- China
- Prior art keywords
- gene
- termite
- dsrna
- termites
- black
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000256602 Isoptera Species 0.000 title claims abstract description 47
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 36
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims abstract description 41
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000002689 soil Substances 0.000 claims abstract description 9
- 241000894006 Bacteria Species 0.000 claims abstract description 8
- 239000002773 nucleotide Substances 0.000 claims abstract description 8
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 8
- 241000607715 Serratia marcescens Species 0.000 claims description 12
- 239000013604 expression vector Substances 0.000 claims description 6
- 238000003259 recombinant expression Methods 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 abstract description 15
- 241000607479 Yersinia pestis Species 0.000 abstract description 8
- 238000011161 development Methods 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 230000000443 biocontrol Effects 0.000 abstract description 4
- 238000013461 design Methods 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 3
- 230000030279 gene silencing Effects 0.000 abstract description 3
- 230000037440 gene silencing effect Effects 0.000 abstract description 3
- 238000012271 agricultural production Methods 0.000 abstract description 2
- 238000013459 approach Methods 0.000 abstract description 2
- 229960003444 immunosuppressant agent Drugs 0.000 abstract description 2
- 239000003018 immunosuppressive agent Substances 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000014509 gene expression Effects 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 15
- 238000011282 treatment Methods 0.000 description 15
- 230000009368 gene silencing by RNA Effects 0.000 description 13
- 241001387505 Heterotermes tenuis Species 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 241000238631 Hexapoda Species 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 7
- 241001509990 Rhinotermitidae Species 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 5
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- XJCPMUIIBDVFDM-UHFFFAOYSA-M nile blue A Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4[O+]=C3C=C(N)C2=C1 XJCPMUIIBDVFDM-UHFFFAOYSA-M 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 101150028074 2 gene Proteins 0.000 description 2
- 108020004459 Small interfering RNA Proteins 0.000 description 2
- 244000061457 Solanum nigrum Species 0.000 description 2
- 235000002594 Solanum nigrum Nutrition 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 239000007640 basal medium Substances 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000087 hemolymph Anatomy 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000008073 immune recognition Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000004055 small Interfering RNA Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 125000003345 AMP group Chemical group 0.000 description 1
- 241000218642 Abies Species 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 1
- DAEFQZCYZKRTLR-ZLUOBGJFSA-N Ala-Cys-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(O)=O DAEFQZCYZKRTLR-ZLUOBGJFSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- VZKXOWRNJDEGLZ-WHFBIAKZSA-N Cys-Asp-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O VZKXOWRNJDEGLZ-WHFBIAKZSA-N 0.000 description 1
- BVFQOPGFOQVZTE-ACZMJKKPSA-N Cys-Gln-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O BVFQOPGFOQVZTE-ACZMJKKPSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- PODFFOWWLUPNMN-DCAQKATOSA-N Gln-His-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PODFFOWWLUPNMN-DCAQKATOSA-N 0.000 description 1
- SBHVGKBYOQKAEA-SDDRHHMPSA-N Gln-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCC(=O)N)N)C(=O)O SBHVGKBYOQKAEA-SDDRHHMPSA-N 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- TZCGZYWNIDZZMR-NAKRPEOUSA-N Ile-Arg-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)O)N TZCGZYWNIDZZMR-NAKRPEOUSA-N 0.000 description 1
- TZCGZYWNIDZZMR-UHFFFAOYSA-N Ile-Arg-Ala Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(C)C(O)=O)CCCN=C(N)N TZCGZYWNIDZZMR-UHFFFAOYSA-N 0.000 description 1
- DZMWFIRHFFVBHS-ZEWNOJEFSA-N Ile-Tyr-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N DZMWFIRHFFVBHS-ZEWNOJEFSA-N 0.000 description 1
- 108700001097 Insect Genes Proteins 0.000 description 1
- DBSLVQBXKVKDKJ-BJDJZHNGSA-N Leu-Ile-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O DBSLVQBXKVKDKJ-BJDJZHNGSA-N 0.000 description 1
- OPTCSTACHGNULU-DCAQKATOSA-N Lys-Cys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCCN OPTCSTACHGNULU-DCAQKATOSA-N 0.000 description 1
- 240000003293 Magnolia grandiflora Species 0.000 description 1
- 235000008512 Magnolia grandiflora Nutrition 0.000 description 1
- 241001599018 Melanogaster Species 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000866536 Odontotermes formosanus Species 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- IILUKIJNFMUBNF-IHRRRGAJSA-N Phe-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O IILUKIJNFMUBNF-IHRRRGAJSA-N 0.000 description 1
- NGNNPLJHUFCOMZ-FXQIFTODSA-N Pro-Asp-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 NGNNPLJHUFCOMZ-FXQIFTODSA-N 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 241000204046 Termitidae Species 0.000 description 1
- PEYSVKMXSLPQRU-FJHTZYQYSA-N Trp-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N)O PEYSVKMXSLPQRU-FJHTZYQYSA-N 0.000 description 1
- VTFWAGGJDRSQFG-MELADBBJSA-N Tyr-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O VTFWAGGJDRSQFG-MELADBBJSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000011217 control strategy Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229920006227 ethylene-grafted-maleic anhydride Polymers 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a targeted silencing black wing soil termite antibacterial peptideOftermicin2The dsRNA of the gene and the application thereof in termite control. Wherein, the black wing soil termitesOftermicin2The nucleotide sequence of the gene is SEQ ID NO:1. the invention is based on antibacterial peptidesOftermicin2The gene designs dsRNA, establishes the black wing soil termite by feeding methodOftermicin2RNA interference system and obtains obvious gene silencing effect in the black wing termite feedingOftermicin2RNAi technology applications provide technical support. In addition, the present patent utilizes established subterranean termitesOftermicin2RNA interference system for controlling black wing soil termiteOftermicin2The dsRNA is combined with biocontrol bacteria, so that the control effect of biocontrol bacteria can be obviously improved. The invention lays a theoretical foundation for the development of human and animal safety immunosuppressants, provides a new theory for biological control of pests, and finally provides a new strategy and a new approach for pest control for green agricultural production and sustainable development in China.
Description
Technical Field
The invention relates to the technical field of biology, in particular to an Oftermitis melanogaster antibacterial peptide Oftermisin 2 gene and application thereof.
Background
Termites are one of the most well known pests in the world, a social insect, and have strong fertility and viability. Mainly endangering house construction, agriculture and forestry crops, reservoir earth dams, cable bridges, traffic facilities and the like, and frequently carrying out corrosion on non-cellulose substances. The black wing subterranean termite Odontotermes formosanus (Shiraki) belongs to higher termites, and is one type of subterranean termite. Most of the time the activity is underground. The bark, shallow woody layers and roots are mainly harmed by workers. The outer part of the damaged trunk forms a large ant road, and the growth vigor declines. When the tree enters the xylem, the trunk withers; especially for seedlings, death is very easy to occur. The mud is used as mud cover and mud line when the food is harmful, and the mud cover is formed by surrounding the whole dry body when the food is serious, and the characteristics are obvious. Subterranean termites are the primary pests of reservoirs and river dams and can often cause dam leakage, slumping and breach (Li Dong, et al, 2001; cai Banghua, et al, 1965; xu Zhenhai, 2004; xu Zhide, et al, 2007). Because the nest of the black wing subterranean termite is very hidden, the damage caused by the black wing subterranean termite is not easily detected, and when the damage is detected, the damage is very huge. In addition, the black wing soil termites are more omnivorous and have wider hazard range, and can be harmful to more than 100 plants including camphor trees, fir trees, magnolia grandiflora, maple and the like (Huang Qiu, etc.; 2005).
At present, the prevention and treatment of the black wing termites still mainly depend on the traditional chemical pesticides, but the problems of medicament residues and the like are increasingly serious, and the black wing termites have potential threat to human and animal health and ecological environment. Therefore, it is imperative to discover new biological control methods and to explore new control strategies for subterranean termites. RNA interference (RNAi) refers to the phenomenon of silencing target gene expression in eukaryotes by inducing homologous mRNA degradation from double-stranded RNA (ds RNA), and is generally performed by introducing exogenous dsRNA or small interfering RNA (small interfering RNA, si RNA) in studies of insect gene function. RNAi can achieve sustainable control of pest populations by selectively interfering with the expression of insect key genes, and is expected in the field of pest control. Insect antimicrobial peptides (antimicrobial peptides, AMPs) are a class of polypeptide substances with broad-spectrum antimicrobial activity that appear in the haemolymph of insects when they are infected with external stimuli or microorganisms. They are generally composed of 10-50 amino acid residues, are positively charged, amphiphilic, cationic, water-soluble polypeptides, and are linear or have a cyclic structure, which is formed by linking one or more pairs of dipeptide amino acid residues. In fully metamorphosed insects, the antimicrobial peptides are rapidly synthesized and secreted into the haemolymph by the fat body and various epithelial cells, whereas in non-fully metamorphosed insects, the antimicrobial peptides are first synthesized in healthy insect blood cells and secreted into the haemoglobins after being stimulated or infected. Silencing the gene can reduce the termite's ability to resist infection by pathogenic microorganisms, ultimately leading to their death, and therefore, it is expected that dsRNA is designed for antimicrobial peptide genes for termite control by RNA interference techniques.
Disclosure of Invention
The invention aims to provide an application of dsRNA of a black wing subterranean termite offtermicin 2 gene in termite control. The inventor discovers that the gene of the subterranean termite Oftermicin2 is designed based on the gene and is introduced into termites for the first time, so that the subterranean termites can be effectively prevented and treated.
Specifically, the invention provides an antibacterial peptide Oftermicin2 gene of black wing soil termite, and the nucleotide sequence of the Oftermicin2 gene is shown as SEQ ID NO:1. The corresponding amino acid sequence is shown as SEQ ID NO: 2.
The invention further provides application of the Oftermicin2 gene in termite control.
Meanwhile, the invention provides an Oftermicin2dsRNA for preventing termites, which consists of SEQ ID NO:1, and the nucleotide sequence shown in the specification.
The invention also provides DNA encoding the above-mentioned Oftermicin2 dsRNA.
Further, the present invention provides a recombinant expression vector comprising the DNA encoding dsRNA described above.
The invention also provides a host bacterium for transforming the recombinant expression vector.
In another aspect, the invention features a method of controlling termites, comprising the steps of:
as another method for controlling termites, termites can be co-fed with Oftermicin2dsRNA and serratia marcescens SM1, wherein the dsRNA consists of the amino acid sequence as set forth in SEQ ID NO:1, and the nucleotide sequence shown in the specification.
The beneficial effects are that: the invention designs dsRNA based on immune recognition protein Oftermicin2 gene, researches and establishes a feeding method to perform an Oftermicin2 RNA interference system, obtains obvious gene silencing effect when fed to the Alftermicin, and provides theoretical basis for Oftermicin2 RNAi technology application. Meanwhile, by constructing a dsRNA expression system using HT115 strain, the interference cost is reduced. The invention successfully interferes the expression of the immune recognition protein Oftermicin2 gene by using the system, and discovers that the sensitivity of the Oftermicin2 gene-silenced black-termitid to Serratia marcescens SM1 strain is obviously improved. Experiments show that the use of the Oftermicin2dsRNA and SM1 simultaneously improves the death rate of termites obviously, which proves that the control effect of biocontrol bacteria can be improved. The application provides a theoretical basis for the application of the Oftermicin2dsRNA in termite control.
Drawings
FIG. 1 is a view of total RNA electrophoresis of subterranean termites;
FIG. 2 shows the cloning sequence and deduced amino acid sequence of Oftermicin2;
FIG. 3 shows the amount of Oftermicin2 expressed after Serratia marcescens treatment of Solanum nigrum;
FIG. 4 is a graph showing the results of electrophoresis of recombinant plasmids L4440-dsOftermicin2 and L4440-dsGFP, wherein 1 is L4440-dsGFP and 2 is L4440-dsOftermicin2;
FIG. 5 shows the result of dsRNA electrophoresis, wherein 1 is dsGFP and 2 is dsOftermicin2;
FIG. 6 shows the relative expression levels of the target gene 6h after dsRNA feeding, wherein: different lower case letters represent significant differences between treatments;
FIG. 7 is a survival analysis after 6h of dsRNA treatment, wherein ABCDE is 14, 24, 34, 44, 54h, respectively; f is survival analysis graph, dashed line is time of treatment with SM 1.
Detailed Description
The experimental methods used in the following examples are conventional methods unless otherwise specified, and the materials, reagents and the like used are commercially available reagents and materials unless otherwise specified.
Experimental materials and methods involved in the examples:
(1) Test insects: the black wing soil termite is collected from period holding city of Jiangsu province, and after being collected back, the termite nest is placed in an insect incubator under the dark condition of 27 ℃ for breeding.
(2) Culture of Serratia marcescens SM1
Culture medium: bacterial basal medium (g/L): peptone 10g, beef extract 20g, naCl 2g, K 2 HPO 4 2g, 18g of agar with pH of 7.2-7.4.
Bacterial seed medium (g/L): peptone 10g, yeast extract 20g, naCl 2g, K 2 HPO 4 2g。
Bacterial fermentation medium (g/L): peptone 10g, soybean oil 30g, naCl 2g, K 2 HPO 4 2g。
The separated Serratia marcescens strain SM1 is transferred into a bacterial basal medium, cultured for 24 hours under the dark condition of 27 ℃, and single colony is obtained after streak separation. The single colony was taken out, placed in a 250mL conical flask containing 50mL of seed culture medium after sterilization, and cultured in a constant temperature shaker at 30℃and 200r/min for 12 hours, followed by seed liquid culture. Then, 70ml of the seed solution after the cultivation was added to 250ml of the fermentation medium, and the mixture was cultured in a shaking incubator at a rotation speed of 200r/min for 36 hours at a temperature of 30℃and taken out for use after the cultivation.
(3) Determination of Serratia marcescens SM1 fermentation broth concentration
Within a certain range, as the number of cells in Serratia marcescens SM1 fermentation broth increases, so does the OD600 value.
The present invention will be described in further detail with reference to the following specific examples, which will aid in understanding the present invention, but the scope of the present invention is not limited to the following examples.
EXAMPLE 1 cloning of the Oftermicin2 Gene
(1) Primer design: according to the sequence of the Oftermicin2 obtained by transcriptome data, primer5 software is used for designing a primer:
Oftermicin2F:CCAAACCTGCAACAAAGC;
Oftermicin2R:TTGGCTTGTAAGAACAAACTGC。
(2) Amplification of cDNA and TA cloning:
trizol method extracts total RNA from termites.
Total RNA extraction results from black-wing termites (see fig. 1). The OD260/OD280 ratio of the RNA detected by the nucleic acid detector is 1.855 and is 1.8-2.0, which indicates that the quality of the RNA is qualified, and the next experiment can be carried out.
cDNA was synthesized by reverse transcription using total RNA as a template and referring to TaKaRa First Strand cDNA Synthesis Kit. The reverse transcription system is shown in Table 1.
TABLE 1
The cDNA is used as a template, and primer Oftermicin2F, oftermicin R is used for amplification to obtain 267bp fragment, the sequence is shown as SEQ ID NO.1, the full-length sequence comprises a 186bp open reading frame, and 62 amino acid polypeptides are encoded, as shown in figure 2. The PCR amplification reaction system is shown in Table 2, and the PCR amplification reaction conditions are: pre-denaturation at 94℃for 3min; denaturation at 94℃for 30s, annealing at 56℃for 30s, extension at 72℃for 30s, for a total of 35 cycles; finally, the extension is carried out for 10min at 72 ℃. PCR amplified products were detected by 1% agarose gel electrophoresis and photographed under a gel imaging system. And (5) purifying and recycling the PCR products identified to be correct through a gel recycling kit. The TA cloning conditions are shown in Table 3. The gel recovery product was ligated with pClone007 at room temperature for 1-5min, the ligation product transformed into e.coli DH5 a competent cells, the ligation product transformed:
(1) E.coli DH5 alpha competent cells are taken out from a refrigerator at the temperature of minus 80 ℃ and dissolved in ice water;
(2) Adding 10uL of the ligation product into 100uL E.coli DH5α competent cells by using a pipette, and ice-setting for 30min;
(3) Heat shock is carried out for 45s in a water bath at 42 ℃, and the obtained product is immediately placed in ice water for standing for 2min after being taken out;
(4) Adding a liquid culture medium of SOC or LB, and carrying out shaking culture at 37 ℃ and 200rpm for 1h;
(5) 200uL of bacterial liquid is coated on LB solid medium containing Amp penicillin (final concentration 50 mug/mL), and the culture is inverted and carried out overnight in a 37 ℃ incubator.
The transformation product is cultivated in LB (amp+) solid medium for 12-16 h. Positive clones were selected, identified by bacterial liquid PCR, and the recombinant plasmid containing the correct insert was designated pClone007-Oftermicin2 and sequenced by the company.
TABLE 2
TABLE 3 Table 3
EXAMPLE 2 Induction of expression of Oftermicin2 by Serratia marcescens SM1 on subterranean termites
Contamination experiment: filter paper was first laid on the bottom of each 6cm dish and wetted with water. And then placing 20 head black wing soil termite workers with better activity and mature development into the culture dish. Each concentration (2.139X 10) was measured using Serratia marcescens SM1 fermentation medium as control (ck) 11 cells/ml、2.139×10 10 cells/ml、2.139×10 9 cells/ml) were dropped on the subterranean termites using a 0.12. Mu.L micropipette, and each group was repeated three times. After dripping, placing in dark environment at 25deg.C, observing and collecting samples, collecting samples at 3, 6, 12, and 24 hr respectively, and placingPlacing at-80deg.C for preservation.
As shown in FIG. 3, it was found by fluorescent quantitative experiments that the concentration was 2.139X 10 9 After cells/ml of SM1 is used for treating the black wing termites, the Oftermicin2 is obviously up-regulated in the treatment of 3 hours, 6 hours and 12 hours; with a concentration of 2.139X 10 10 After cells/ml of SM1 is used for treating the black wing termites, the Oftermicin2 is obviously up-regulated in 3 hours, 6 hours and 12 hours, and the expression level is obviously down-regulated in 24 hours; 2.139 ×10 11 After cells/ml of SM1 is used for treating the black wing termites, the expression quantity of Oftermicin2 is up-regulated only at 6h and 12h, and the expression quantity is obviously down-regulated at 24 h.
EXAMPLE 3 Synthesis and inducible expression of dsRNA of termite Oftermicin2 Gene
(1) Primer design of dsRNA of termite Oftermicin2 gene.
The potential RNAi target site is predicted at 6 bp-182 bp of Oftermicin2 through on-line software. According to the sequence of the Oftermicin2 obtained by cloning, primer5 software is used for designing a primer:
dsOftermicin2F:ATTTGCGGCCGC AAGACCGTTACTAGCCTACTTGT;
dsOftermicin2R:CCCAAGCTTT GCCGTTAGGATTATACACACAT,
and upstream and downstream of the enzyme cutting sites NotI and HindIII (bold letters are enzyme cutting sites, italics are protective bases). Meanwhile, the primers for designing GFP are as follows:
dsGFP F:ATCGGAGCTCAGTTGAACGGATCCATCTTCA;
dsGFP R:CCCAAGCTTAGAACTTTTCACTGGA,
and upstream and downstream, restriction sites (SacI) and HindIII were introduced. All primers were synthesized by Tianjin Optimu Biotechnology Co.
(2) Synthesis of dsRNA of termite Oftermicin2 gene.
PCR amplification is carried out by using the full-length plasmid pClone007-Oftermicin2 with correct sequencing as a template and using designed upstream and downstream primers dsOftermicin2F and dsOftermicin2R for synthesizing dsRNA; the PCR amplification reaction conditions were: pre-denaturation at 94℃for 3min; denaturation at 94℃for 30s, annealing at 49℃for 30s, extension at 72℃for 30s, for a total of 35 cycles; finally, the extension is carried out for 10min at 72 ℃. PCR amplified products were detected by 1% agarose gel electrophoresis and photographed under a gel imaging system. And (5) purifying and recycling the PCR products identified to be correct through a gel recycling kit.
(3) Construction of dsRNA expression vectors.
The 500bp fragment was cloned using the existing GFP nucleic acid sequence in the laboratory as template. And the target fragment and the L4440 vector are linked after enzyme digestion, so that the L4440-dsOftermicin2 and L4440-dsGFP recombinant plasmid are successfully constructed. The results of the electrophoresis of the L4440-dsOftermicin2 and L4440-dsGFP recombinant plasmids are shown in FIG. 4, wherein 1 is L4440-dsGFP and 2 is L4440-dsOftermicin2.
Specifically, taking L4440-dsOftermicin2 as an example, carrying out double digestion on the PCR product with NotI and HindIII, and recovering a target fragment; simultaneously, the two enzymes are used for double enzyme digestion of the expression vector L4440, and the target vector is recovered. The target fragment double cleavage system and the vector double cleavage system are shown in tables 4 and 5, respectively. The target fragment and the target vector are connected for 16h at 16 ℃ under the action of T4DNA ligase. The ligation product was transformed into E.coli DH 5. Alpha. Competent cells, LB (double antibody against ampicillin and tetracycline) solid medium for 12h. After positive clones were selected and identified by restriction enzyme, the recombinant plasmid containing the correct insert was designated as L4440-dsOftermicin2 and was sequenced by company.
TABLE 4 Table 4
TABLE 5
(4) Induction expression and extraction of dsRNA.
HT115 strain dsRNA containing L4440-dsOftermicin2 and L4440-dsGFP recombinant plasmids are respectively subjected to induction expression (figure 5), target bands are 183bp and 500bp, the expected sizes of the dsOftermicin2 and the dsGFP are consistent, and the construction of the interference vector is successful. The total RNA after induction of expression was then digested with DNase I and RNase A.
Taking L4440-dsOftermicin2 as an example, a recombinant plasmid of properly sequenced L4440-dsOftermicin2 was transformed into HT115 (DE 3) competent bacteria, and coated on a plasmid containing ampicillin (50. Mu.g. Multidot.mL) -1 ) And tetracycline (12.5. Mu.g.mL) -1 ) The double antibody is cultured on LB solid medium at 37 ℃ in an inverted way overnight. The monoclonal was inoculated into an ampicillin-containing medium (50. Mu.g. ML) -1 ) And tetracycline (12.5. Mu.g.mL) -1 ) In LB liquid medium of double antibody, 37 ℃,220 r.min -1 When the culture was performed with shaking until the OD600 of the bacterial liquid was about 0.5-0.6, IPTG (final concentration of 0.8 mM) was added, the culture was continued with shaking at 37℃for 220 r.min-1 for 3 hours, and then dsRNA was extracted with TaKaRa RNAiso Plus. dsRNA was digested using RNAse H and DNAse I. Quantification was performed using Eppendorf BioSpectrometer basic to give a final concentration of 1. Mu.g/. Mu.L. Storing in-80 deg.c refrigerator for use.
Example 4 detection of the amount of Oftermicin2 expressed after RNAi.
The dsRNA of Oftermicin2 was first mixed with Nile Blue and 400. Mu.l was then added dropwise to the filter paper at the bottom of a 6cm dish. The treatment group was 1. Mu.g/. Mu.L of dsOftermicin2 (dsOftermicin 2), and the control group was dsGFP and 20% Nile Blue in water (ck). 20 termites were added to each dish and each group was repeated 3 times. Placing in dark environment at 25deg.C, observing and collecting sample at 6 hr, collecting termite with blue intestinal tract, and storing at-80deg.C.
The genes were subjected to a fluorescent quantitative PCR (qRT-PCR) experiment to examine the changes in the expression levels of the genes at different times. The fluorescent quantitative primers were as follows (RPS 18 and GAPDH as reference genes):
q-Oftermicin2 F:CCGTTACTAGCCTACTTGTCTTT
q-Oftermicin2 R:GTCCATCACAGAACGCTCTTA
q-RPS18F:ATGGCAAACCCCCGTCAGTA
q-RPS18R:CATACCACGATGCGCACGAA
q-GAPDHF:TCGTATTGGCCGTCTTGTGC
q-GAPDHR:AGCGACCATGGGTGGAATCAT;
the fluorescent quantitative PCR reaction system is as follows:
the reaction procedure:
95℃30s
{95℃ 5s,60℃34s}30cycles
{95℃ 15s,60℃1min,95℃15s}
In order to detect the change of the expression quantity of the target gene under sampling at different intervals after the feeding of the Oftermicin2dsRNA, the control group and the treatment group of the black wing termite cDNA samples are subjected to real-time fluorescence quantitative PCR detection, and the result shows that the interference efficiency is 71.84% after 6 hours after the feeding of the dsRNA, and the relative expression quantity of the target gene is obviously lower than that of the other two groups (figure 6).
Example 5 variation of sensitivity of subterranean Solanum nigrum to Serratia marcescens SM1 after RNAi
dsRNA was first mixed with Nile Blue and 400. Mu.L was then added dropwise to the filter paper at the bottom of a 6cm dish. The treatment group was 1. Mu.g/. Mu.L of dsOftermicin2, and the control group was dsGFP and 20% Nile Blue in water. And selecting the highest time for down-regulating the Oftermicin2 expression quantity to start the bioassay. 20 termites were added to each dish and each group was repeated 3 times. The bioassay experiments were performed by setting the normal fermentation medium treatment (CK), SM1 treatment (CK-SM 1), dsGFP treatment (dsGFP), SM1 treatment after dsGFP interference (dsGFP-SM 1), dsOftermicin2 treatment (dsOftermicin 2), and SM1 treatment after dsOftermicin2 interference (dsOftermicin 2-SM 1). The data were observed and recorded in a dark environment at 25 ℃.
After feeding dsOfermicin 26 h to the black-fin termites, carrying out SM1 infection experiments, and carrying out biological measurement to find that the survival rate of the black-fin termites after RNAi is obviously reduced compared with that of the black-fin termites without RNAi, and analyzing data for 14, 24, 34, 44 and 54h, wherein the death rate of dsOfermicin 2 groups treated by SM1 is highest at 14h, 24h and 34h and respectively reaches about 10%, about 50% and about 90%; at 44h and 54h, mortality was 100% for dsOftermicin2 treated with SM1, with mortality reaching around 50% for both the CK group treated with SM1 and the dsGFP group treated with SM1, higher than for the control group (CK group and dsGFP group) but lower than for dsOftermicin2 group treated with SM 1.
It is also evident from the survival curves that the survival rate of SM1 treated dsOftermicin2 group was significantly lower than that of the control group (CK group and GFP group) (fig. 7).
In conclusion, the technology of propagating dsRNA by bacteria is utilized for the first time to synthesize the subterranean termite Oftermicin2dsRNA, a subterranean termite Oftermicin2 RNA interference system by a feeding method is established, and obvious gene silencing effect is obtained when the subterranean termite is fed in the subterranean termite, so that technical support is provided for the application of the subterranean termite Oftermicin2 RNAi technology. The system is used for successfully interfering the expression of the antibacterial peptide Oftermicin2 gene, and the fact that the sensitivity of the Oftermicin2 gene-silenced black-termicin to Serratia marcescens SM1 strain is obviously improved is found. Experiments show that the use of the Oftermicin2dsRNA and SM1 simultaneously improves the death rate of termites obviously, which proves that the control effect of biocontrol bacteria can be improved. The application provides a theoretical basis for the application of the Oftermicin2dsRNA in termite control. The invention lays a theoretical foundation for the development of human and animal safety immunosuppressants, provides a new theory for biological control of pests, and finally provides a new strategy and a new approach for pest control for green agricultural production and sustainable development in China.
The invention provides a termite control thought and method, the method and the way of realizing the technical scheme are a plurality of, the above is only the preferred embodiment of the invention, it should be pointed out that a plurality of improvements and modifications can be made by the person skilled in the art without departing from the principle of the invention, and the improvements and modifications are also considered as the protection scope of the invention. The components not explicitly described in this embodiment can be implemented by using the prior art.
Sequence listing
<110> university of Nanjing forestry
<120> subterranean termite antibacterial peptide Oftermicin2 gene and application thereof
<160> 14
<170> SIPOSequenceListing 1.0
<210> 1
<211> 189
<212> DNA
<213> nucleotide sequence of Oftermicin2 Gene (Artificial Sequence)
<400> 1
atgaagaccg ttactagcct acttgtcttt ctggtcgtcg tctgcttgct cattgcacag 60
cacccggcag acgcagcctg cgacttccaa cagtgttggg ccacgtgcca ggcacagcac 120
caaatctact tcataagagc gttctgtgat ggacccgatt gcaaatgtgt gtataatcct 180
aacggctag 189
<210> 2
<211> 62
<212> PRT
<213> Oftermicin2 amino acid sequence (Artificial Sequence)
<400> 2
Met Lys Thr Val Thr Ser Leu Leu Val Phe Leu Val Val Val Cys Leu
1 5 10 15
Leu Ile Ala Gln His Pro Ala Asp Ala Ala Cys Asp Phe Gln Gln Cys
20 25 30
Trp Ala Thr Cys Gln Ala Gln His Gln Ile Tyr Phe Ile Arg Ala Phe
35 40 45
Cys Asp Gly Pro Asp Cys Lys Cys Val Tyr Asn Pro Asn Gly
50 55 60
<210> 3
<211> 18
<212> DNA
<213> Oftermicin2F(Artificial Sequence)
<400> 3
ccaaacctgc aacaaagc 18
<210> 4
<211> 22
<212> DNA
<213> Oftermicin2R(Artificial Sequence)
<400> 4
ttggcttgta agaacaaact gc 22
<210> 5
<211> 35
<212> DNA
<213> dsOftermicin2F(Artificial Sequence)
<400> 5
atttgcggcc gcaagaccgt tactagccta cttgt 35
<210> 6
<211> 32
<212> DNA
<213> dsOftermicin2R(Artificial Sequence)
<400> 6
cccaagcttt gccgttagga ttatacacac at 32
<210> 7
<211> 31
<212> DNA
<213> dsGFP F(Artificial Sequence)
<400> 7
atcggagctc agttgaacgg atccatcttc a 31
<210> 8
<211> 25
<212> DNA
<213> dsGFP R(Artificial Sequence)
<400> 8
cccaagctta gaacttttca ctgga 25
<210> 9
<211> 23
<212> DNA
<213> q-Oftermicin2 F(Artificial Sequence)
<400> 9
ccgttactag cctacttgtc ttt 23
<210> 10
<211> 21
<212> DNA
<213> q-Oftermicin2 R(Artificial Sequence)
<400> 10
gtccatcaca gaacgctctt a 21
<210> 11
<211> 20
<212> DNA
<213> q-RPS18F(Artificial Sequence)
<400> 11
<210> 12
<211> 20
<212> DNA
<213> q-RPS18R(Artificial Sequence)
<400> 12
<210> 13
<211> 20
<212> DNA
<213> q-GAPDHF(Artificial Sequence)
<400> 13
<210> 14
<211> 21
<212> DNA
<213> q-GAPDHR(Artificial Sequence)
<400> 14
agcgaccatg ggtggaatca t 21
Claims (7)
1. Antibacterial peptide of black wing soil termiteOftermicin2A gene, wherein theOftermicin2The nucleotide sequence of the gene is shown in SEQ ID NO:1.
2. The method of claim 1Oftermicin2The application of the gene in termite control.
3. A dsRNA for controlling termites, characterized in that it consists of SEQ ID NO:1, and the nucleotide sequence shown in the specification.
4. A DNA encoding the dsRNA of claim 2.
5. A recombinant expression vector comprising the DNA encoding the dsRNA of claim 4.
6. A host bacterium transformed with the recombinant expression vector of claim 5.
7. A method for controlling termites is characterized by usingOftermicin2Co-feeding termites with dsRNA and serratia marcescens SM1, wherein the dsRNA consists of the amino acid sequence as set forth in SEQ ID NO:1, and the nucleotide sequence shown in the specification.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111256412.8A CN116024219B (en) | 2021-10-27 | 2021-10-27 | Subterranean termite antibacterial peptide Oftermicin gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111256412.8A CN116024219B (en) | 2021-10-27 | 2021-10-27 | Subterranean termite antibacterial peptide Oftermicin gene and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116024219A true CN116024219A (en) | 2023-04-28 |
CN116024219B CN116024219B (en) | 2024-08-20 |
Family
ID=86090152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111256412.8A Active CN116024219B (en) | 2021-10-27 | 2021-10-27 | Subterranean termite antibacterial peptide Oftermicin gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116024219B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113088520A (en) * | 2021-04-01 | 2021-07-09 | 华中农业大学 | dsRNA (double-stranded ribonucleic acid) and application thereof in termite control |
CN113122546A (en) * | 2021-04-23 | 2021-07-16 | 华中农业大学 | SeBP gene of odontotermes formosanus and application of dsRNA thereof in combining metarhizium anisopliae in termite control |
CN113234724A (en) * | 2021-05-18 | 2021-08-10 | 华中农业大学 | dsRNA (double-stranded ribonucleic acid) for preventing and treating termites and application thereof |
-
2021
- 2021-10-27 CN CN202111256412.8A patent/CN116024219B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113088520A (en) * | 2021-04-01 | 2021-07-09 | 华中农业大学 | dsRNA (double-stranded ribonucleic acid) and application thereof in termite control |
CN113122546A (en) * | 2021-04-23 | 2021-07-16 | 华中农业大学 | SeBP gene of odontotermes formosanus and application of dsRNA thereof in combining metarhizium anisopliae in termite control |
CN113234724A (en) * | 2021-05-18 | 2021-08-10 | 华中农业大学 | dsRNA (double-stranded ribonucleic acid) for preventing and treating termites and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN116024219B (en) | 2024-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110938118B (en) | Plant immune activation protein PC2 secreted by phytophthora infestans and application thereof | |
CN110894218B (en) | Plant immune activator protein SCR50 secreted by phytophthora infestans and application thereof | |
CN116024219B (en) | Subterranean termite antibacterial peptide Oftermicin gene and application thereof | |
CN104530204B (en) | A kind of rape cecropin B gene nPRP1 and its application | |
CN108559753B (en) | Application of wheat stripe rust PSTG _17694 gene in stripe rust prevention and treatment and stripe rust resistant wheat cultivation method | |
CN108103042B (en) | Anti-verticillium wilt related receptor-like protein kinase GhPR5K, coding gene thereof and application thereof | |
CN115927349B (en) | Subterranean termite gram negative bacteria recognition protein GNBP2 gene and application thereof | |
CN109971654A (en) | Common big thrips biocontrol microorganisms gradually narrow Lecanicillium lecanii SCAUDCL-53 and its application | |
CN116024220A (en) | Termite black-bone antibacterial peptide Oftermicin1 gene and application thereof | |
CN114989283A (en) | Application of TCP19 protein in regulation and control of rice sheath blight resistance | |
CN112852862B (en) | Application of arabidopsis small peptide signal molecule RGF7 gene | |
CN110564702B (en) | Chilo suppressalis growth and development related protein ND, coding gene, dsRNA interference sequence and application thereof | |
CN109913480B (en) | Locust uridine diphosphate glucuronosyltransferase gene and application thereof | |
KR20030015010A (en) | New biopesticide using WT#3-1 gene from Erwinia pyrifoliae WT#3, novel pathogen that affects Asian pear trees | |
CN115896117A (en) | Termite formosana gram-negative bacterium recognition protein GNBP3 gene and application thereof | |
CN113150087A (en) | Plant immune activator protein Fg62 secreted by fusarium graminearum and application thereof | |
CN115896116A (en) | Termite formosana gram-negative bacteria recognition protein GNBP1 gene and application thereof | |
CN111378670A (en) | Separated adelphocoris suturalis Taiman gene and encoded protein thereof | |
KR100578746B1 (en) | 1 Pathogen induced pepper geneCAPIP1 sequence and probing method of plant disease resistance and environmental stresses using the same | |
CN110563828B (en) | Chilo suppressalis male specificity lethal associated protein MSL3, coding gene, dsRNA interference sequence and application thereof | |
CN112314631B (en) | Biological source pesticide and preparation method thereof | |
CN112029772B (en) | Gustavus gene and application thereof, dsRNA synthesized by Gustavus gene and preparation method and application of dsRNA | |
CN111235088B (en) | Holotrichia parallela embryonic cell line and application thereof | |
CN113337523B (en) | Application of CRN effector protein gene in inducing plant resistance | |
KR100796164B1 (en) | Plant membrane receptor protein gene camrp1 from pepper and environmental stress resistant transgenic plants using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |